UBS Group
ORCX

UBS Group’s Defiance Daily Target 2X Long ORCL ETF ORCX Stock Holding History

UBS Group’s Portfolio ORCX Stock Details ORCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.5K Buy
+767
New +$26.8K ﹤0.01% 7912

Other funds holding ORCX

HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
KF
KKM Financial Chicago, Illinois $563M AUM 28.2% 1-Year Est. Return
SG
StoneX Group New York $1.86B AUM 21.3% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
CJ
Caitlin John Brighton, Michigan $167M AUM 23.74% 1-Year Est. Return
NS
NBC Securities Birmingham, Alabama $1.33B AUM 24% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return

UBS Group's ORCX Position: Q1 2026 in Review

UBS Group opened a new position in Defiance Daily Target 2X Long ORCL ETF (ORCX) in Q1 2026: 767 shares worth $20.5K. The stake represents ﹤0.01% of the portfolio and ranks #7912 among its holdings.

10 funds tracked by Wall St. Rank hold ORCX as of Q1 2026.

  • UBS Group held 767 shares of Defiance Daily Target 2X Long ORCL ETF worth $20.5K as of Q1 2026.
  • Defiance Daily Target 2X Long ORCL ETF was a new UBS Group position in Q1 2026.
  • Defiance Daily Target 2X Long ORCL ETF made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #7912 holding.
  • 10 funds tracked by Wall St. Rank held Defiance Daily Target 2X Long ORCL ETF as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.